These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3728462)

  • 1. Removal of aluminum during hemodialysis: effect of different dialyzer membranes.
    Muirhead N; Hollomby DJ; Leung FY; Mitton R; Henderson AR; Keown PA; Stiller CR
    Am J Kidney Dis; 1986 Jul; 8(1):51-5. PubMed ID: 3728462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid removal of DFO-chelated aluminum during hemodialysis using polysulfone dialyzers.
    Molitoris BA; Alfrey AC; Alfrey PS; Miller NL
    Kidney Int; 1988 Jul; 34(1):98-101. PubMed ID: 3172641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of desferrioxamine infusion on red blood cell aluminum.
    Umeda M; Umimoto K; Tsurusaki K; Izumi N; Kishimoto T; Maekawa M
    ASAIO Trans; 1988; 34(3):297-9. PubMed ID: 3196524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accelerated removal of deferoxamine mesylate-chelated aluminum by charcoal hemoperfusion in hemodialysis patients.
    Delmez J; Weerts C; Lewis-Finch J; Windus D; Slatopolsky E
    Am J Kidney Dis; 1989 Apr; 13(4):308-11. PubMed ID: 2705449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of aluminum overload using a cartridge with immobilized desferrioxamine.
    Anthone S; Ambrus CM; Kohli R; Min I; Anthone R; Stadler A; Stadler I; Vladutiu A
    J Am Soc Nephrol; 1995 Oct; 6(4):1271-7. PubMed ID: 8589296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deferoxamine and coated charcoal hemoperfusion to remove aluminum in dialysis patients.
    McCarthy JT; Milliner DS; Schmidt DF; Schniepp BJ; Kurtz SB; Johnson WJ
    Kidney Int; 1988 Dec; 34(6):804-8. PubMed ID: 3210542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of dialyzers used in shortened dialysis.
    Petersen J; Ramsey KD; Kang MS; Yeh IT
    ASAIO Trans; 1989; 35(3):338-40. PubMed ID: 2688714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Removal of aluminum from chronic dialysis patients by administration of desferrioxamine and dialysis.
    Ono T; Iwamoto N; Kataoka H; Taniguchi Y; Sakai Y; Kunitomo T
    ASAIO Trans; 1986; 32(1):52-7. PubMed ID: 3778761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aluminum removal: AN69-S membrane versus a combined cuprophane and charcoal filter.
    Valentijn RM
    Kidney Int Suppl; 1988 Mar; 24():S171. PubMed ID: 3163041
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of dialyzer geometry during hemodialysis with cuprophane membranes.
    Taylor JE; McLaren M; Mactier RA; Henderson IS; Stewart WK; Belch JJ
    Kidney Int; 1992 Aug; 42(2):442-7. PubMed ID: 1405328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiocontrast removal by dialysis membranes.
    Gouge SF; Moore J; Atkins F; Hirszel P
    Blood Purif; 1991; 9(4):182-7. PubMed ID: 1818581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dialysis membranes and PTH changes during hemodialysis in patients with secondary hyperparathyroidism.
    De Francisco AL; Amado JA; Prieto M; Alcalde G; Sanz de Castro S; Ruiz JC; Morales P; Arias M
    Nephron; 1994; 66(4):442-6. PubMed ID: 8015649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of vancomycin in patients undergoing hemodialysis with polyacrylonitrile.
    Torras J; Cao C; Rivas MC; Cano M; Fernandez E; Montoliu J
    Clin Nephrol; 1991 Jul; 36(1):35-41. PubMed ID: 1889149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of dialyzer membranes on beta-2 microglobulin production in Thai hemodialysis patients.
    Domrongkitchaiporn S; Chuncharunee S; Archararit N; Atamasirikul K; Vanichakarn S
    J Med Assoc Thai; 1997 Sep; 80 Suppl 1():S138-43. PubMed ID: 9347661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the dialyzer membrane on the overall phosphate kinetics during hemodialysis.
    Katopodis KP; Chala A; Koliousi E; Takouli L; Kalaitzidis R; Theodorou J; Siamopoulos KC
    Blood Purif; 2005; 23(5):359-64. PubMed ID: 16088103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Aluminum poisoning in dialysis patients--diagnosis and therapy].
    Vogelsang U
    Schweiz Rundsch Med Prax; 1994 Jun; 83(24):738-56. PubMed ID: 8023059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical evaluation of four different high-flux hemodialyzers under conventional conditions in vivo.
    Sombolos K; Tsitamidou Z; Kyriazis G; Karagianni A; Kantaropoulou M; Progia E
    Am J Nephrol; 1997; 17(5):406-12. PubMed ID: 9382156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anaphylatoxin formation during hemodialysis: effects of different dialyzer membranes.
    Chenoweth DE; Cheung AK; Henderson LW
    Kidney Int; 1983 Dec; 24(6):764-9. PubMed ID: 6609269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of dialysis membranes on the convective transport of middle molecules.
    De Francisco AL; Gordillo J; Cotorruelo JG; Ruiz L; Gonzalez M; Morales P; Arias M
    Int J Artif Organs; 1986 Nov; 9(6):421-6. PubMed ID: 3818117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of hemodialysis membrane type on parathyroid hormone removal.
    Kudlac H; Fielding AM; Williams AJ
    Miner Electrolyte Metab; 1994; 20(5):245-9. PubMed ID: 7700210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.